A systematic review and meta-analysis of risks and benefits with breast reduction in the public healthcare system: priorities for further research.

ABSTRACT:

Background

There is no consensus for when publicly funded breast reduction is indicated and recommendations in guidelines vary greatly, indicating a lack of evidence and unequal access. The primary aim of this review was to examine risks and benefits of breast reduction to treat breast hypertrophy. Secondary aims were to examine how the studies defined breast hypertrophy and indications for a breast reduction.

Methods

A systematic literature search was conducted in PubMed, MEDLINE All, Embase, the Cochrane Library, and PsycInfo. The included articles were critically appraised, and certainty of evidence was assessed using the GRADE approach. Meta-analyses were performed when possible.

Results

Fifteen articles were included; eight reporting findings from four randomised

SUBMITTER: Widmark-Jensen E 

PROVIDER: S-EPMC8436537 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature